|
2023-09-13 |
2023-09-11 |
B
Purchase
|
Celebi John
President and CEO
Executive Director
|
500
+0.5%
0.85
USD 425
|
500
+0.5%
|
0.85
|
USD 425
|
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Large shareholder
|
955,738
-100.0%
1.58
USD 1,510,066
|
955,738
-100.0%
|
1.58
|
USD 1,510,066
|
|
|
2023-06-02 |
2023-06-01 |
S
Sale
|
Apeiron Investment Group Ltd.
Large shareholder
|
2,485,923
-100.0%
1.58
USD 3,927,758
|
2,485,923
-100.0%
|
1.58
|
USD 3,927,758
|
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Large shareholder
|
1,100
+0.0%
1.60
USD 1,763
|
1,100
+0.0%
|
1.60
|
USD 1,763
|
|
|
2023-02-27 |
2023-02-23 |
B
Purchase
|
Apeiron Investment Group Ltd.
Large shareholder
|
1,100
+0.0%
1.62
USD 1,777
|
1,100
+0.0%
|
1.62
|
USD 1,777
|
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
1,203
+0.0%
3.20
USD 3,850
|
1,203
+0.0%
|
3.20
|
USD 3,850
|
|
|
2022-03-02 |
2022-03-02 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
1,203
+0.0%
3.20
USD 3,850
|
1,203
+0.0%
|
3.20
|
USD 3,850
|
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,458
+0.0%
3.60
USD 8,849
|
2,458
+0.0%
|
3.60
|
USD 8,849
|
|
|
2022-03-01 |
2022-03-01 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,458
+0.0%
3.60
USD 8,849
|
2,458
+0.0%
|
3.60
|
USD 8,849
|
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
42
+0.0%
3.60
USD 151
|
42
+0.0%
|
3.60
|
USD 151
|
|
|
2022-03-01 |
2022-02-28 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
42
+0.0%
3.60
USD 151
|
42
+0.0%
|
3.60
|
USD 151
|
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,500
+0.0%
3.65
USD 9,125
|
2,500
+0.0%
|
3.65
|
USD 9,125
|
|
|
2022-02-28 |
2022-02-25 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,500
+0.0%
3.65
USD 9,125
|
2,500
+0.0%
|
3.65
|
USD 9,125
|
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
15,000
+0.3%
3.63
USD 54,450
|
15,000
+0.3%
|
3.63
|
USD 54,450
|
|
|
2022-02-24 |
2022-02-24 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
15,000
+0.3%
3.63
USD 54,450
|
15,000
+0.3%
|
3.63
|
USD 54,450
|
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
2,500
+0.0%
3.80
USD 9,500
|
2,500
+0.0%
|
3.80
|
USD 9,500
|
|
|
2022-02-24 |
2022-02-23 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
2,500
+0.0%
3.80
USD 9,500
|
2,500
+0.0%
|
3.80
|
USD 9,500
|
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
15,000
+0.3%
3.97
USD 59,550
|
15,000
+0.3%
|
3.97
|
USD 59,550
|
|
|
2022-02-22 |
2022-02-18 |
B
Purchase
|
Peyer James
Non-Executive Director
Large shareholder
|
15,000
+0.3%
3.97
USD 59,550
|
15,000
+0.3%
|
3.97
|
USD 59,550
|
|
|
2022-02-22 |
2022-02-17 |
B
Purchase
|
Cambrian BioPharma Inc
Large shareholder
|
4,949
+0.1%
4.17
USD 20,637
|
4,949
+0.1%
|
4.17
|
USD 20,637
|
|
